Abstract
Male factor underlies >50% infertility cases worldwide, yet treatment mainly relies on Artificial Reproduction Technology (ART). There is clearly an unmet clinical need for new treatment options for the infertile male. A wealth of literature considers both positive and negative effects of the phosphodiesterase inhibitor (PDEI) pentoxiphylline on sperm. It is used clinically by some, but its role is controversial.
Full Text
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call